GKOS

NYSE Glaukos Corp

Nov 11, 2026 · 10:03 AM ET DELAYED Market Open

$239.61 ↑ +3.42 (+1.45%) Trading Up from the previous close of $236.19, $1.53 below the day’s high of $241.14

YTD change: +112.21%
vs 20-day SMA: +18.92%
vs 200-day SMA: +64.82%

Price ranges

Previous day

$235.09 $241.35

open $237.94 close $236.19

-$1.75 (-0.74%)

Today

$237.54 $241.14

open $237.54 now $239.61

+$2.07 (+0.87%)

Past week

$218.77 $255.19

from $233.04 now $239.61

+$6.57 (+2.82%)

Past month

$163.13 $255.19

from $165.50 now $239.61

+$74.11 (+44.78%)

This year

$93.96 $255.19

from $112.91 now $239.61

+$126.70 (+112.21%)

Price & Performance

+100.82 (+74.48%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good

The stock is 6.1% away from all-time highs of $255.19
GKOS is up 112% since the beginning of the year
GKOS is up 167% over the past 12 months
GKOS is up 45% over the past 1 month
8% of all GKOS investors are betting against GKOS
Number of investors short GKOS has gone up 16% versus last month

GKOS reads very good: price sits above both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is +162.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $0.47

Earnings momentum +6.6% Quarterly EPS growth

Quarterly change +6.6%

Valuation

P/E ratio N/A

Enterprise value $14.2B

Beta 0.72

Balance sheet & scale

IncomeN/A

Revenue$690.3M

Cash$336.7M

Debt$102.0K

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE

Sector Manufacturing

Sub Sector Miscellaneous Manufacturing

Market cap $14.2B

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard A. Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.

Competitor comparison

Ticker	Company	Price	Change
SYK	Stryker Corporation	$324.29	-0.44%
STE	STERIS plc	$257.12	+0.07%
SNN	Smith & Nephew plc Sponsored ADR	$30.92	-0.42%
WILYY	Demant A/S Unsponsored ADR	$29.18	+2.84%
WILLF	Demant A/S	$53.40	-0.82%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.